Share on StockTwits

Baxano Surgical (NASDAQ:BAXS) CEO Kenneth Michael Reali bought 10,000 shares of the company’s stock on the open market in a transaction that occurred on Friday, August 15th. The stock was purchased at an average price of $0.38 per share, for a total transaction of $3,800.00. Following the completion of the acquisition, the chief executive officer now directly owns 141,128 shares in the company, valued at approximately $53,629. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Baxano Surgical (NASDAQ:BAXS) traded up 5.77% during mid-day trading on Tuesday, hitting $0.3903. 309,695 shares of the company’s stock traded hands. Baxano Surgical has a 52 week low of $0.36 and a 52 week high of $1.99. The stock has a 50-day moving average of $0.50 and a 200-day moving average of $0.86. The company’s market cap is $18.9 million.

Baxano Surgical (NASDAQ:BAXS) last posted its quarterly earnings results on Tuesday, August 5th. The company reported ($0.18) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.14) by $0.04. Analysts expect that Baxano Surgical will post $-0.58 EPS for the current fiscal year.

Baxano Surgical Inc, formerly TranS1 Inc, is a medical device company focused on designing, developing and marketing products that implement its approach to treat degenerative conditions of the spine affecting the lower lumbar region.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.